Precision medicine white paper

Download your free white paper

Every year, two million Americans are hospitalized due to adverse drug reactions. Using genomics as a primary tool for individualizing patient care is the future of medicine. Genetic screening can offer a new level of confidence in medication efficacy and a higher level of patient trust and comfort with treatment decisions.

Includes:

• Patient populations and specialties that stand to benefit from pre-emptive pharmacogenomic testing

• The importance of PGx workflow integration

• High-priced drugs where genomic testing can detect inefficacy in advance

• Other selected research excerpts